Ambulatory ECG monitoring for syncope and collapse in United States, Europe, and Japan: The patients' viewpoint

dc.authoridSutton, Richard/0000-0002-5710-1094|ALTINSOY, Meltem/0000-0002-3494-5999
dc.contributor.authorAltinsoy, Meltem
dc.contributor.authorSutton, Richard
dc.contributor.authorKohno, Ritsuko
dc.contributor.authorSakaguchi, Scott
dc.contributor.authorMears, Robin K.
dc.contributor.authorBenditt, David G.
dc.date.accessioned2025-10-24T18:08:47Z
dc.date.available2025-10-24T18:08:47Z
dc.date.issued2021
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractBackground: Practice guidelines provide clinicians direction for the selection of ambulatory ECG (AECG) monitors in the evaluation of syncope/collapse. However, whether patients' understand differences among AECG systems is unknown. Methods and Results: A survey was conducted of USA (n = 99), United Kingdom (UK)/Germany (D) (n = 75) and Japan (n = 40) syncope/collapse patients who underwent diagnostic AECG monitoring. Responses were quantitated using a Likert-like 7-point scale (mean +/- SD) or percent of patients indicating a Top 2 box (T2B) for a particular AECG attribute. Patient ages and diagnosed etiologies of syncope/collapse were similar across geographies. Patients were queried on AECG attributes including the ability to detect arrhythmic/cardiac causes of collapse, instructions received, ease of use, and cost. Patient perception of the diagnostic capabilities and ease of use did not differ significantly among the AECG technologies; however, USA patients had a more favorable overall view of ICM/ILRs (T2B: 42.4%) than did UK/D (T2B: 28%) or Japan (T2B: 17.5%) patients. Similarly, US patient rankings for education received regarding device choice and operation tended to be higher than UK/D or Japan patients; nevertheless, at their best, the Likert scores were low (approximately 4.7-6.0) suggestig need for education improvement. Finally, both US and UK/D patients were similarly concerned with ICM costs (T2B, 31% vs 20% for Japan). Conclusions: Patients across several geographies have a similar but imperfect understanding of AECG technologies. Given more detailed education the patient is likely to be a more effective partner with the clinician in establishing a potential symptom-arrhythmia correlation.
dc.description.sponsorshipMedtronic Inc, Minneapolis, Minnesota; Dr Earl E Bakken Family
dc.description.sponsorshipThe authors wish to acknowledge the patients who participated in this survey. The survey reported here was funded by Medtronic Inc, Minneapolis, Minnesota. Dr Benditt is supported in part by a grant from the Dr Earl E Bakken Family in support of heart-brain research. Ms Mears is a Medtronic employee.
dc.identifier.doi10.1002/joa3.12560
dc.identifier.endpage1030
dc.identifier.issn1880-4276
dc.identifier.issn1883-2148
dc.identifier.issue4
dc.identifier.pmid34386128
dc.identifier.scopus2-s2.0-85106282418
dc.identifier.scopusqualityQ3
dc.identifier.startpage1023
dc.identifier.urihttps://doi.org/10.1002/joa3.12560
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3287
dc.identifier.volume37
dc.identifier.wosWOS:000653118400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal Of Arrhythmia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20251023
dc.subjectambulatory ECG monitoring; insertable cardiac monitors; syncope
dc.titleAmbulatory ECG monitoring for syncope and collapse in United States, Europe, and Japan: The patients' viewpoint
dc.title.alternativeAmbulatory ECG monitoring for syncope and collapse in United States, Europe, and Japan: The patients’ viewpoint
dc.typeArticle

Dosyalar